Dulhunty J - Search Results

1

End points for phase II trials in intensive care: recommendations from the Australian and New Zealand Clinical Trials Group consensus panel meeting.

Young P, Hodgson C, Dulhunty J, Saxena M, Bailey M, Bellomo R, Davies A, Finfer S, Kruger P, Lipman J, Myburgh J, Peake S, Seppelt I, Streat S, Tate R, Webb S; ANZICS Clinical Trials Group. Young P, et al. Among authors: dulhunty j. Crit Care Resusc. 2012 Sep;14(3):211-5. Crit Care Resusc. 2012. PMID: 22963216

2

Increased fluid resuscitation can lead to adverse outcomes in major-burn injured patients, but low mortality is achievable.

Dulhunty JM, Boots RJ, Rudd MJ, Muller MJ, Lipman J. Dulhunty JM, et al. Burns. 2008 Dec;34(8):1090-7. doi: 10.1016/j.burns.2008.01.011. Epub 2008 May 12. Burns. 2008. PMID: 18468802

3

Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study.

Dulhunty JM, Lipman J, Finfer S; Sepsis Study Investigators for the ANZICS Clinical Trials Group. Dulhunty JM, et al. Intensive Care Med. 2008 Sep;34(9):1654-61. doi: 10.1007/s00134-008-1160-2. Epub 2008 May 27. Intensive Care Med. 2008. PMID: 18504549

4

Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units.

Holley A, Dulhunty J, Blot S, Lipman J, Lobo S, Dancer C, Rello J, Dimopoulos G. Holley A, et al. Among authors: dulhunty j. Int J Antimicrob Agents. 2009 Jun;33(6):554.e1-7. doi: 10.1016/j.ijantimicag.2008.10.035. Epub 2009 Jan 22. Int J Antimicrob Agents. 2009. PMID: 19167196

5

Do burn patients cost more? The intensive care unit costs of burn patients compared with controls matched for length of stay and acuity.

Patil V, Dulhunty JM, Udy A, Thomas P, Kucharski G, Lipman J. Patil V, et al. Among authors: dulhunty jm. J Burn Care Res. 2010 Jul-Aug;31(4):598-602. doi: 10.1097/BCR.0b013e3181e4d6a4. J Burn Care Res. 2010. PMID: 20489652

6

A survey of antibiotic prescribing practices in Australian and New Zealand intensive care units.

Dulhunty JM, Webb SA, Paterson DL, Bellomo R, Myburgh J, Roberts JA, Lipman J. Dulhunty JM, et al. Crit Care Resusc. 2010 Sep;12(3):162-70. Crit Care Resusc. 2010. PMID: 21261573

7

Antimicrobial utilisation in 37 Australian and New Zealand intensive care units.

Dulhunty JM, Paterson D, Webb SA, Lipman J. Dulhunty JM, et al. Anaesth Intensive Care. 2011 Mar;39(2):231-7. doi: 10.1177/0310057X1103900212. Anaesth Intensive Care. 2011. PMID: 21485671

8

Determining authorship in multicenter trials: a systematic review.

Dulhunty JM, Boots RJ, Paratz JD, Lipman J. Dulhunty JM, et al. Acta Anaesthesiol Scand. 2011 Oct;55(9):1037-43. doi: 10.1111/j.1399-6576.2011.02477.x. Epub 2011 Jun 20. Acta Anaesthesiol Scand. 2011. PMID: 21689076 Review.

9

Continuous beta-lactam infusion in critically ill patients: the clinical evidence.

Abdul-Aziz MH, Dulhunty JM, Bellomo R, Lipman J, Roberts JA. Abdul-Aziz MH, et al. Among authors: dulhunty jm. Ann Intensive Care. 2012 Aug 16;2(1):37. doi: 10.1186/2110-5820-2-37. Ann Intensive Care. 2012. PMID: 22898246 Free PMC article.

10

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.

Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J. Dulhunty JM, et al. Clin Infect Dis. 2013 Jan;56(2):236-44. doi: 10.1093/cid/cis856. Epub 2012 Oct 16. Clin Infect Dis. 2013. PMID: 23074313 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters